Semaglutide Dosing Schedule: The Complete Titration Guide

# Semaglutide Dosing Schedule: The Complete Titration Guide

Semaglutide isn't one dose — it's a progression. The way you escalate through doses significantly affects both your results and your experience with side effects. Here's everything you need to know about the titration schedule.

Why Dose Escalation Exists

Semaglutide works through GLP-1 receptor agonism, which affects GI motility, gastric emptying, and the hunger/satiety signaling centers in the brain. The gastrointestinal side effects common in the first few weeks — nausea, constipation, diarrhea — are largely a function of how quickly the receptor pathway is saturated.

Starting at the maintenance dose would cause most people significant nausea and likely lead to treatment discontinuation. The titration schedule exists to allow your body to adapt gradually, with side effects typically diminishing significantly by week 4-8 as tolerance develops.

Additionally, physicians can assess your response at lower doses — some patients achieve excellent appetite suppression at 0.5mg and never need to escalate to 1mg or 2.4mg. More isn't always better.

The Standard Semaglutide Titration Schedule

Starting dose: 0.25mg weekly (weeks 1-4) The lowest dose, used to initiate treatment. At 0.25mg, most people notice mild appetite reduction but significant weight loss isn't typical. The primary purpose is GI tolerance building.

First escalation: 0.5mg weekly (weeks 5-8) Many patients notice substantially increased appetite suppression at this dose. Meaningful weight loss typically begins here. If tolerating 0.25mg without significant side effects, escalation to 0.5mg happens at week 5.

Second escalation: 1mg weekly (weeks 9-12) The standard maintenance dose used in clinical practice for type 2 diabetes management (original Ozempic indication). For weight loss, many patients remain at 1mg long-term. The jump from 0.5mg to 1mg often produces noticeable additional appetite suppression.

Third escalation: 1.7mg weekly (weeks 13-16) Ozempic maxes at 2mg; the Wegovy protocol (FDA-approved specifically for weight loss) includes 1.7mg and 2.4mg tiers. Not all compounded semaglutide programs include these higher doses, but they produce additional weight loss for patients who plateau.

Maintenance dose: 2.4mg weekly (week 17+) The highest approved dose for weight loss (Wegovy). Clinical trials at 2.4mg showed 15%+ average body weight reduction over 68 weeks. Some patients achieve full results at lower doses and never escalate this far.

What Happens If You Have Side Effects

The most common side effects are nausea, constipation, and diarrhea — particularly in the first 2-4 weeks at any new dose level.

If nausea is significant: Slow down. Staying at 0.25mg for an additional 4 weeks before escalating is completely reasonable. Some physicians use a more gradual 8-12 week entry protocol rather than the standard 4-week periods.

If you vomit after injection: Note the timing. Semaglutide has a long half-life and absorption continues over 24+ hours, so a single vomiting episode hours after injection doesn't mean the dose is lost. Call your physician if vomiting persists.

For nausea management: - Take your injection in the evening rather than the morning — nausea typically peaks 6-12 hours post-injection, and sleeping through the peak period is much more comfortable - Avoid large, high-fat, or high-sugar meals for several hours after injection - Stay hydrated — dehydration worsens GI symptoms - Ginger tea, peppermint, and small frequent meals can help with nausea

For constipation: Hydration is the most important intervention. Many people on semaglutide eat significantly less and naturally consume less water. Aim for 2-3L daily. Adding fiber (psyllium husk) and light movement helps. Constipation typically resolves as your body adapts.

Injection Timing: Does Day of Week Matter?

For most people, no — semaglutide has a 7-day half-life (roughly), so weekly injections maintain reasonably consistent blood levels. However, some considerations:

Pick a day and stick with it. Consistency reduces the chance of missed or doubled doses. Many people choose Mondays or Fridays as anchors.

Avoid injection right before high-stakes social eating. If you have a major dinner Saturday night, taking your injection Friday evening means you'll likely be at peak appetite suppression Saturday — which can make social eating uncomfortable. Some people shift injection day to Sunday to front-load suppression in the work week and ease up slightly by the weekend.

Evening vs morning: Most patients do better with evening injections, primarily for nausea management. The difference in efficacy is negligible.

How Long to Stay at Each Dose

The general rule: stay at a dose for at least 4 weeks before escalating. If you're tolerating it well and not yet achieving desired appetite suppression, escalate on schedule.

Reasons to pause escalation: - Ongoing significant nausea at current dose (side effects typically improve with time at the same dose) - Excellent appetite suppression at current dose — more isn't necessarily better - Physician recommendation based on your clinical response

Don't rush escalation for its own sake. Patients who achieve sustainable appetite suppression at 1mg and stay there long-term often have better overall outcomes than patients who rush to 2.4mg and have more side effects.

Dose Reduction and Maintenance

Some patients who reach their goal weight or are maintaining reduce to a lower dose rather than stopping entirely. Stopping semaglutide completely typically results in appetite returning to baseline, and weight regain without lifestyle changes in place.

Common maintenance strategies: - Continue at the current dose indefinitely - Reduce to the lowest effective dose (often 0.5mg or 1mg) - Trial stopping with a plan to restart if weight rebounds significantly (typically >10% of peak loss)

What to Expect in Terms of Weight Loss Timing

Weeks 1-4 (0.25mg): Minimal weight loss, GI adaptation. Focus is tolerance, not results.

Weeks 5-12 (0.5-1mg): Most patients see 2-4% body weight loss. Appetite suppression is noticeable.

Months 3-6 (1-2.4mg): The primary weight loss phase. Average loss 8-12% of body weight by month 6 in clinical trials.

Months 6-18: Plateau and continuation. The plateau at 9-12 months is normal — weight loss slows as your body adapts. This is when the lifestyle habits matter most.

Clinical trial result (68 weeks): 15% average body weight reduction at 2.4mg. Range is wide — some patients lose 5%, others lose 25%+. Genetics, starting weight, lifestyle factors, and adherence all affect outcomes.

Working With Your Prescribing Physician

Your titration schedule should be personalized, not just defaulted to the standard 4-week protocol. Factors your physician should be incorporating:

• Your GI response at each dose level
• Your appetite suppression response (are you actually eating less?)
• Your weight loss trajectory
• Any relevant medical history (kidney function, history of pancreatitis, etc.)

Marrow's physician team reviews your progress regularly and adjusts dosing based on your actual response — not just advancing on autopilot because the calendar says so.